Golden Biotechnology Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 81.77 million compared to TWD 88.83 million a year ago. Net loss was TWD 443.84 million compared to TWD 391.38 million a year ago. Basic loss per share from continuing operations was TWD 3.35 compared to TWD 3.11 a year ago. Diluted loss per share from continuing operations was TWD 3.35 compared to TWD 3.11 a year ago.